Fallopian Tube Adenocarcinoma
Also known as: Adenocarcinomas of the Fallopian Tubes
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00062 | Albumin human | 1 | Active Not Recruiting | 1 |
| DB17450 | Albumin-stabilized nanoparticle (130 nm) | 1 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 1 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Terminated | 1 |
| DB15017 | Enoblituzumab | 1 | Completed | 1 |
| DB15732 | FT516 | 1 | Completed | 1 |
| DB14865 | Human interleukin-2 | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Terminated | 1 |
| DB14905 | Emactuzumab | 2 | Terminated | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Terminated | 1 |
| DB16694 | Pegcetacoplan | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 3 | Active Not Recruiting | 1 |
| DB04964 | Oregovomab | 3 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 3 | Active Not Recruiting | 1 |